Steve Gorlin sold $128k of BIVI
director at BIOVIE INC.. 75,680 shares at an average of $1.69, traded Dec 1, 2023, filed Dec 6, 2023.
Score components
- +15RoleDirector
- +11Trade size$128k at market
- +20Share of holdings soldSold 62% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -27.7%, 3m -53.1%, 6m -72.3%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001520138-23-000534, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 9, 2023 | AGrant or award Common Stock | +46,358 | $0.00 | $0 | 122,038 | Dec 6, 2023 |
| Dec 1, 2023 | SOpen-market sale Common Stock | -75,680 | $1.69 | $128k | 46,358 | Dec 6, 2023 |
Related signals
Other insiders at BIOVIE INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 55Moderate | BIOVIE INC. | Cuong Do V President & CEO | $32k 15,210 shares | +1677% | |
| 47Moderate | BIOVIE INC. | Joanne Wendy Kim Chief Financial Officer | $5,450 2,500 shares | +266% | |
| 38Weak | BIOVIE INC. | Amy Suzon Chappell director | $1,570 727 shares | - | |
| 40Moderate | BIOVIE INC. | Joseph M Palumbo Chief Medical Officer | $10k 4,843 shares | +406% | |
| 46Moderate | BIVIbuy BIOVIE INC. | Cuong Do V President & CEO | $18k 10,000 shares | +17% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.